Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dresden scientists generate model systems for retinal disease research

14.04.2016

Scientists at the German Center for Neurodegenerative Diseases (DZNE) and the DFG Research Center for Regenerative Therapies Dresden (CRTD) – Cluster of Excellence at the Technische Universität Dresden have created 3D retina tissue derived from stem cells. To generate these so called retina organoids, the researchers developed a novel protocol that is reliable and more efficient than previous methods. Based on these model systems they are planning to investigate eye diseases and potential strategies for treatment. They report on this in the scientific journal “Stem Cell Reports.”

Age-related macular degeneration and other diseases of the retina, which result in the progressive loss of neuronal cells in the eyes, are among the most frequent causes of impaired vision and blindness. To date, there are no cures for these diseases and knowledge on their mechanisms is scarce.


Retinal Organoid under the microscope

© CRTD

“Stem cell based technologies promise new avenues to study these conditions in the laboratory. In particular, we will profit from human cell based disease model systems,” explains Dr. Mike Karl, who leads a research group at the DZNE’s Dresden site and the CRTD.

Thus, Karl and his colleagues have developed a new protocol for the production of organ-like tissues, also called “organoids”, which resemble the retina of mice and humans. These model systems are generated in cell culture from pluripotent stem cells, which have the power to develop into any type of cell in our body.

The Biotechnology Center (BIOTEC) of the TU Dresden including the research group of Dr. Konstantinos Anastassiadis also participated in the project. From studying these retinal organoids the scientists hope to gain new insights on the causes of retinal diseases. “We thereby intend to facilitate the development of potential therapeutic drugs and treatment concepts,” explains Karl.

Compared to previous methods, the Dresden scientists were able to significantly improve the production of 3D retina organoids. Their new approach results in high production efficiency and reproducibility. “Our experimental protocol reliably recapitulates key characteristics of retinal development in vivo. Furthermore, it offers flexibility. We could therefore tailor the organoids to specific questions that we want to study,” comments DZNE researcher Manuela Völkner, lead author of the current publication. In particular, the researchers succeeded to raise the production of cone photoreceptor neurons. These sensory cells are essential for our color vision and high visual acuity, especially for reading.

“We now have the means to produce larger amounts of these precious cells, which is a premise for certain studies. This includes basic research as well as studies in regenerative medicine,” explains Karl. “For instance, several labs are pursuing the idea to restore vision due to cell loss by retinal cell transplantation. There is certainly a long way to go. But our model systems might help to develop such therapeutic strategies.”

These most recent successes of Dresden researchers once again demonstrate the potential that is harnessed through the close collaboration of several disciplines at the life science campus in Dresden-Johannstadt.


Scientific publication:

„Retinal Organoids from Pluripotent Stem Cells Efficiently Recapitulate Retinogenesis“, Manuela Völkner, Marlen Zschätzsch, Maria Rostovskaya, Rupert W. Overall, Volker Busskamp, Konstantinos Anastassiadis, Mike O. Karl, Stem Cell Reports,
http://dx.doi.org/10.1016/j.stemcr.2016.03.001

Press Contact:

Franziska Clauß, M.A.
CRTD Press Officer
Phone: +49 351 458 82065, e-Mail: franziska.clauss@crt-dresden.de

Dr. Marcus Neitzert
DZNE Press and Public Relations
Phone: +49 228 43302271, e-Mail: marcus.neitzert@dzne.de

Founded in 2006, the DFG Research Center for Regenerative Therapies Dresden (CRTD), Cluster of Excellence at the TU Dresden has passed the third phase of the Excellence Initiative which aims at promoting top-level research and improving the quality of German universities and research institutions. The goal of the CRTD is to explore the body's self-healing potential and to develop completely new, regenerative therapies for hitherto incurable diseases. The key areas of research include haematology and immunology, diabetes, neurodegenerative diseases and bone regeneration. At the moment, eight professors and ten group leaders are working at the CRTD – integrated into an interdisciplinary network of 87 members at seven different institutions within Dresden. In addition, 21 partners from industry are supporting the network. The synergies in the network allow for a fast translation of results from basic research to clinical applications.
www.crt-dresden.de

The German Center for Neurodegenerative Diseases (DZNE) investigates the causes of diseases of the nervous system and develops strategies for prevention, treatment and care. It is an institution within the Helmholtz Association of German Research Centers with nine sites across Germany (Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten). The DZNE cooperates closely with universities, their clinics and other research facilities. Cooperation partners in Dresden are the Technische Universität Dresden and the Universitätsklinikum Carl Gustav Carus.

www.dzne.de/en 

Enclosures:

Portrait: Dr. Mike O. Karl © CRTD

Microscope image: Retinal Organoid under the microscope: The following cell types are labeled in a tissue section: Cyan = photoreceptors (marker CRX), red = bipolar neurons & glia cells (marker VSX2), green = amacrine neurons (marker hPAX6GFP) © CRTD

Infographic: Production of retinal organoids from pluripotent stem cells © CRTD based on Stem Cell Reports)

Weitere Informationen:

http://dx.doi.org/10.1016/j.stemcr.2016.03.001

Franziska Clauß | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Predicting unpredictability: Information theory offers new way to read ice cores

07.12.2016 | Earth Sciences

Sea ice hit record lows in November

07.12.2016 | Earth Sciences

New material could lead to erasable and rewriteable optical chips

07.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>